The ALS2 Gene Spastic Paralysis Infantile Onset Ascending NGS Genetic DNA Test is an advanced diagnostic tool that utilizes Next Generation Sequencing (NGS) technology to analyze genetic factors associated with infantile onset spastic paralysis. This test plays a vital role in identifying the underlying genetic causes of neurological disorders, enabling healthcare providers to offer targeted interventions and management strategies.
Turnaround time for results is approximately 3 to 4 weeks. The test requires a sample type of blood or extracted DNA, and we recommend a genetic counseling session prior to testing to discuss the clinical history and draw a pedigree chart of affected family members.
We have branches in all major cities in Kenya, including Nairobi, Mombasa, and Kisumu. Our team is dedicated to providing comprehensive genetic testing services and home sample collection options for your convenience.